Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

Publisher： Karger

E-ISSN： 1421-9662|133|1|64-66

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.1, 2014-08, pp. : 64-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Angiogenesis in Acute Myeloid Leukemia and Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 170-176

Karger

Access to resources Recommend Favorite

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Myeloid Leukemia Secondary to a Myelodysplastic Syndrome with t(3;3) (q21;q26) in an HIV Patient Treated with Chemotherapy and Highly Active Antiretroviral Therapy

By  

Acta Haematologica, Vol. 111, Iss. 3, 2004-03 ,pp. : 160-162

Karger

Access to resources Recommend Favorite

Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia Registry

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 208-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite